Evaluation and Management of Delirium in Hospitalized Older Patients



FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.


FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

Am Fam Physician. 2008 Dec 1;78(11):1265-1270.

  An updated article on this topic is available.

Delirium is common in hospitalized older patients and may be a symptom of a medical emergency, such as hypoxia or hypoglycemia. It is characterized by an acute change in cognition and attention, although the symptoms may be subtle and usually fluctuate throughout the day. This heterogeneous syndrome requires prompt recognition and evaluation, because the underlying medical condition may be life threatening. Risk factors for delirium include visual impairment, previous cognitive impairment, severe illness, and an elevated blood urea nitrogen/serum creatinine ratio. Interventions that have been shown to reduce the incidence of delirium in at-risk hospitalized patients include repeated reorientation of the patient to person and place, promotion of good sleep hygiene, early mobilization, correction of dehydration, and the minimization of unnecessary noise and stimuli. The treatment of delirium centers on the identification and management of the medical condition that triggered the delirious state. Nonpharmacologic interventions may be beneficial, but antipsychotic agents may be needed when the cause is nonspecific and other interventions do not sufficiently control symptoms such as severe agitation or psychosis. Although delirium is a temporary condition, it may persist for several months in the most vulnerable patients. Patient outcomes at one year include a higher mortality rate and a lower level of functioning compared with age-matched control patients.

Delirium is characterized by an acute change in cognition and attention. It develops over hours to days and usually fluctuates during the course of the day. It is the most common complication in older patients who are hospitalized, affecting 20 percent of those older than 65 years.1,2 In 10 to 30 percent of older patients admitted to the hospital from the emergency department, delirium is the presenting symptom of a potentially life-threatening condition (e.g., a medication overdose or toxicity, hypoglycemia, hypoxia, sepsis).3 In patients with delirium, the average increase in length of hospital stay is eight days, and mortality rates are twice as high compared with similarly matched patients without delirium.4 Physical and cognitive recovery at six and 12 months is significantly worse in patients with delirium compared with age-matched control patients.4 Adverse outcomes from delirium include aspiration, prolonged immobility and its repercussions, and loss of independence.

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendation Evidence rating References

The Confusion Assessment Method is recommended for the bedside diagnosis of delirium.

C

18, 19

Antipsychotic medications may be considered for selected patients with delirium only when drug treatment is necessary to control delirium symptoms.

C

18, 23

A predictive model can accurately assess a patient's risk of developing delirium.

C

26

Addressing six risk factors (i.e., cognitive impairment, sleep deprivation, dehydration, immobility, vision impairment, and hearing impairment) in at-risk hospitalized patients can reduce the incidence of delirium by 33 percent.

B

27

Hospital staff educational programs have been shown to effectively reduce delirium duration and related mortality.

B

29, 34


A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to http://www.aafp.org/afpsort.xml.

SORT: KEY RECOMMENDATIONS FOR PRACTICE

View Table

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendation Evidence rating References

The Confusion Assessment Method is recommended for the bedside diagnosis of delirium.

C

18, 19

Antipsychotic medications may be considered for selected patients with delirium only when drug treatment is necessary to control delirium symptoms.

C

18, 23

A predictive model can accurately assess a patient's risk of developing delirium.

C

26

Addressing six risk factors (i.e., cognitive impairment, sleep deprivation, dehydration, immobility, vision impairment, and hearing impairment) in at-risk hospitalized patients can reduce the incidence of delirium by 33 percent.

B

27

Hospital staff educational programs have been shown to effectively reduce delirium duration and related mortality.

B

29, 34


A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to http://www.aafp.org/afpsort.xml.

Epidemiology

Although delirium occurs in 11 to 42 percent of hospitalized patients and may affect up to 50 percent of those at high risk,1,5 the condition is unrecognized in up to 70 percent of patients.6 Mortality rates of hospitalized patients with delirium are 22 to 76 percent, and the one-year mortality rate is 35 to 40 percent.4

Although dementia and delirium are thought to be two distinct entities, patients with dementia are prone to delirium; two thirds of cases of delirium occur in patients with underlying cognitive impairment or dementia.7 Patients with dementia are more likely to present to the hospital with delirium, whereas those with no underlying dementia tend to develop delirium during their hospitalization.8

Etiology and Pathophysiology

The pathophysiology of delirium is not well understood. However, it is likely that multiple mechanisms are involved, and research has shown that changes in cerebral perfusion pressure occur in patients with delirium. One small study using single-photon emission computed tomography suggests that perfusion abnormalities can occur in the frontal or parietal areas of the cerebral cortex.9 Therefore, the development of delirium is usually multifactorial and involves the interrelationship between a predisposed patient and exposure to triggering factors.10  Risk factors for developing delirium include underlying dementia, poor functional status, heavy alcohol use, presence of a urinary catheter, and use of multiple medications; metabolic disturbances or use of certain medications can precipitate delirium (Table 111,12). A relatively benign insult may lead to delirium in at-risk patients. In patients who are less vulnerable, delirium usually only develops with a major insult, such as major surgery requiring general anesthesia or a severe illness that requires admission to an intensive care unit.

Table 1.

Risk Factors and Precipitants for Delirium

Risk factors

Age older than 65 years

Dehydration

Dementia

Functional dependence or immobility

Infection at hospital admission

Malnutrition

Multiple comorbidities

Multiple medications

Chronic renal or hepatic impairment

Severe illness, admission to intensive care unit

Vision or hearing impairment

Precipitants

Electrolyte abnormalities

Environmental factors (e.g., excessive noise, interrupted sleep, unnecessary stimuli)

Hypoxia, hypoglycemia, or ischemia

Medications (especially anticholinergics, narcotics, and sedative-hypnotics); see Table 2

Neurologic disorder (e.g., stroke, seizures)

Pain

Sleep deprivation

Surgery

Urinary catheter

Withdrawal from alcohol, illicit drugs, or benzodiazepines


Information from references 11 and 12.

Table 1.   Risk Factors and Precipitants for Delirium

View Table

Table 1.

Risk Factors and Precipitants for Delirium

Risk factors

Age older than 65 years

Dehydration

Dementia

Functional dependence or immobility

Infection at hospital admission

Malnutrition

Multiple comorbidities

Multiple medications

Chronic renal or hepatic impairment

Severe illness, admission to intensive care unit

Vision or hearing impairment

Precipitants

Electrolyte abnormalities

Environmental factors (e.g., excessive noise, interrupted sleep, unnecessary stimuli)

Hypoxia, hypoglycemia, or ischemia

Medications (especially anticholinergics, narcotics, and sedative-hypnotics); see Table 2

Neurologic disorder (e.g., stroke, seizures)

Pain

Sleep deprivation

Surgery

Urinary catheter

Withdrawal from alcohol, illicit drugs, or benzodiazepines


Information from references 11 and 12.

Anticholinergics, narcotic medications, and sedative-hypnotics are common precipitants of delirium. There is substantial evidence that cholinergic deficiency is a factor in the development of delirium.13 The release of cytokines has been shown to increase the permeability of the blood-brain barrier, which may also play a role in the development of the condition.14  Table 2 lists medications that may contribute to the onset of delirium.15

Table 2.

Selected Medications That May Precipitate Delirium

Anticholinergics

Anticonvulsants

Antidepressants

Antihistamines

Antiparkinsonian agents

Antipsychotics

Barbiturates

Benzodiazepines

Histamine H2 blockers

Lithium

Opioid analgesics


Adapted with permission from Zafirau B. Troubleshooting delirium in elderly inpatients. Psychiatric Times. 2007;24(7):64–67. http://www.psychiatrictimes.com/display/article/10168/54886. Accessed July 3, 2008.

Table 2.   Selected Medications That May Precipitate Delirium

View Table

Table 2.

Selected Medications That May Precipitate Delirium

Anticholinergics

Anticonvulsants

Antidepressants

Antihistamines

Antiparkinsonian agents

Antipsychotics

Barbiturates

Benzodiazepines

Histamine H2 blockers

Lithium

Opioid analgesics


Adapted with permission from Zafirau B. Troubleshooting delirium in elderly inpatients. Psychiatric Times. 2007;24(7):64–67. http://www.psychiatrictimes.com/display/article/10168/54886. Accessed July 3, 2008.

Diagnosis

DIFFERENTIAL DIAGNOSIS

Delirium must be differentiated from other conditions that may cause acute confusion. It is important to distinguish if the acute confusion is due to a primary neurologic condition, such as dementia, a psychotic disorder, or a neurovascular insult, or if it is a complication of a systemic illness. Focal neurologic signs are usually present if a neurovascular insult or other neurologic etiologies are the cause.

Dementia can usually be identified in a patient with a history of a progressive decline in memory over months to years. This may be difficult to determine, particularly if no family member is present when the patient is admitted to the hospital. In addition, dementia with Lewy bodies may have features similar to delirium, such as fluctuating symptoms and hallucinations.16 In general, patients with dementia have intact attention and alertness.16

Patients with psychosis usually maintain normal sleep-wake cycles, orientation to person and place, and attention.17 The orientation of patients with depression or severe anxiety is generally preserved, and cognitive performance usually improves with encouragement.17 Acute mania is similar to delirium in that patients may be hyperactive; however, hyperactivity persists throughout a manic episode, whereas patients with delirium usually have interspersed periods of somnolence. Patients with mania are generally oriented, unlike patients with delirium.17

CLINICAL DIAGNOSIS

The diagnosis of delirium is made clinically. American Psychiatric Association guidelines recommend use of the Confusion Assessment Method (CAM) for the detection of delirium.18 The CAM is a modified version of criteria from the Diagnostic and Statistical Manual of Mental Disorders, 4th ed.19 The shorter, four-item CAM can be completed at bedside in less than five minutes and compares favorably to more complex assessments.19 A diagnosis of delirium using the CAM instrument requires an acute onset, a fluctuating course, the presence of inattention, and either disorganized thinking or an altered level of consciousness.19 Patients may exhibit a hyperactive, hypoactive, or mixed subtype of delirium. Patients with hypoactive delirium, which is the most common subtype,20 may be subdued, lethargic, stuporous, or comatose; therefore, it is important to arouse a “sleeping” patient during hospital rounds to assess the level of consciousness. Patients with the hyperactive subtype may be agitated, anxious, disoriented, or delusional. These patients may insist that they are at home and that members of the hospital staff are intruders. The mixed subtype has both hypoactive and hyperactive features. Patients in all subtypes may also exhibit disorganized speech, impaired cognition, memory deficits, sleep-wake cycle disturbances, and labile emotions.

The Mini-Mental State Examination (MMSE) can be used to identify problems with attention and cognition (e.g., orientation to person, place, and date; spelling the word “world” backwards; serial-seven subtraction).16 Although it was developed for patients with dementia and is only 33 percent sensitive for the diagnosis of delirium,11 the MMSE may be helpful in following patients over the course of delirium (scores improve as the condition resolves).16

DIAGNOSTIC TESTING

The following studies may be helpful, depending on history and physical examination findings: serum chemistries, thyroid studies, electrocardiography, serum troponin level, pulse oximetry or arterial blood gas measurement, urinalysis with culture, complete blood count, chest radiography, and lumbar puncture. Neuroimaging is generally not indicated. However, a patient with focal neurologic signs, a history of head trauma, or fever associated with encephalopathy should receive computed tomography of the head. Patients presenting with encephalopathy who have no available history should receive imaging, and patients with fever should additionally receive lumbar puncture. Electroencephalography is rarely needed, unless the cause of delirium is unclear and occult seizure is a consideration.11,16  Table 3 addresses the evaluation of underlying medical conditions that may lead to delirium.21,22

Table 3.

Evaluation of Underlying Medical Conditions That May Lead to Delirium

Condition Evaluation

Acid-base disorders

Basic metabolic panel; arterial blood gas measurement, if an acid-base disorder is suspected or suggested by serum electrolyte levels

Anemia (hemoglobin level < 10 g per dL [100 g per L])

Complete blood count

Dehydration

Physical findings (e.g., reduced skin turgor, dry mucous membranes), orthostatic blood pressure and pulse measurements, urine specific gravity test, serum osmolarity measurement, blood urea nitrogen/serum creatinine ratio

Electrolyte abnormalities (especially sodium, magnesium, and calcium)

Serum chemistries

Endocrine abnormalities (e.g., hyper- or hypothyroidism, Cushing syndrome, adrenal insufficiency)

Thyroid-stimulating hormone level; serum cortisol level or adrenocorticotropic hormone stimulation test, as needed

Hyper- or hypoglycemia

Serum glucose level

Hyper- or hypothermia

Measurement of patient's core temperature

Hypercarbia or hypoxemia

Pulse oximetry; arterial blood gas measurement, as needed

Infection

As indicated: blood cultures, complete blood count, chest radiography, CT, lumbar puncture, urinalysis with culture

Liver failure or insufficiency

Liver function tests and transaminase levels; serum ammonia level, as needed

Medications (especially anticholinergics, narcotic medications, or sedative-hypnotics)

Review of outpatient and inpatient medication use

Myocardial ischemia

Electrocardiography; serum troponin and myoglobin levels, as needed

Pain

Use of pain assessment scales, review of hospitalization (noting recent falls or surgical procedures)

Renal failure or insufficiency

Blood urea nitrogen level, serum creatinine level, urinalysis, estimated glomerular filtration rate

Stroke, including intracerebral hemorrhage

Neurologic examination; CT of the head, as indicated

Surgery (especially orthopedic or cardiac procedures)

Toxicities (e.g., drug or alcohol intoxication or withdrawal, heavy metal poisoning)

Review of social history and occupational or other exposures; serum alcohol level or urine/serum toxicology, as needed

Vasculitis

As indicated: erythrocyte sedimentation rate, highly sensitive C-reactive protein level

Vitamin deficiencies

Serum B12 and folate levels


CT = computed tomography.

Information from references 21 and 22.

Table 3.   Evaluation of Underlying Medical Conditions That May Lead to Delirium

View Table

Table 3.

Evaluation of Underlying Medical Conditions That May Lead to Delirium

Condition Evaluation

Acid-base disorders

Basic metabolic panel; arterial blood gas measurement, if an acid-base disorder is suspected or suggested by serum electrolyte levels

Anemia (hemoglobin level < 10 g per dL [100 g per L])

Complete blood count

Dehydration

Physical findings (e.g., reduced skin turgor, dry mucous membranes), orthostatic blood pressure and pulse measurements, urine specific gravity test, serum osmolarity measurement, blood urea nitrogen/serum creatinine ratio

Electrolyte abnormalities (especially sodium, magnesium, and calcium)

Serum chemistries

Endocrine abnormalities (e.g., hyper- or hypothyroidism, Cushing syndrome, adrenal insufficiency)

Thyroid-stimulating hormone level; serum cortisol level or adrenocorticotropic hormone stimulation test, as needed

Hyper- or hypoglycemia

Serum glucose level

Hyper- or hypothermia

Measurement of patient's core temperature

Hypercarbia or hypoxemia

Pulse oximetry; arterial blood gas measurement, as needed

Infection

As indicated: blood cultures, complete blood count, chest radiography, CT, lumbar puncture, urinalysis with culture

Liver failure or insufficiency

Liver function tests and transaminase levels; serum ammonia level, as needed

Medications (especially anticholinergics, narcotic medications, or sedative-hypnotics)

Review of outpatient and inpatient medication use

Myocardial ischemia

Electrocardiography; serum troponin and myoglobin levels, as needed

Pain

Use of pain assessment scales, review of hospitalization (noting recent falls or surgical procedures)

Renal failure or insufficiency

Blood urea nitrogen level, serum creatinine level, urinalysis, estimated glomerular filtration rate

Stroke, including intracerebral hemorrhage

Neurologic examination; CT of the head, as indicated

Surgery (especially orthopedic or cardiac procedures)

Toxicities (e.g., drug or alcohol intoxication or withdrawal, heavy metal poisoning)

Review of social history and occupational or other exposures; serum alcohol level or urine/serum toxicology, as needed

Vasculitis

As indicated: erythrocyte sedimentation rate, highly sensitive C-reactive protein level

Vitamin deficiencies

Serum B12 and folate levels


CT = computed tomography.

Information from references 21 and 22.

Management and Prevention

The treatment of delirium requires addressing the underlying causes. Initial treatment involves assessing respiratory status, providing adequate oxygenation, evaluating for the presence of acute myocardial or cerebrovascular ischemia, and maintaining hydration. Other general supportive measures should include initiating venous thromboembolism prophylaxis, repositioning the patient often to prevent decubitus ulcers, mobilizing the patient as early as possible, and removing urinary catheters. Physical restraints should be avoided whenever possible.

Drug treatment is used only when other interventions are ineffective in controlling agitation and an underlying cause of delirium has been identified, and treatment of the underlying cause has been initiated. Haloperidol (Haldol) has been the most studied antipsychotic drug for controlling delirium symptoms. Haloperidol and atypical antipsychotics are recommended if drug treatment is necessary 18,23  (Table 411). However, there are no published randomized controlled trials to establish the safety and effectiveness of any antipsychotic drug for the management of delirium symptoms.24 A recent systematic review recommended larger comparative trials to determine the safety and effectiveness of atypical antipsychotics in patients with delirium.25 Future drug treatment for delirium may include the use of procholinergic agents to increase acetylcholine activity in the brain, selective dopamine antagonists, and drugs that enhance cerebrovascular flow (e.g., anti-inflammatory or antiplatelet agents).

Table 4.

Pharmacologic Treatment of Delirium

Medication Dosage Adverse effects Comments

Conventional antipsychotics

Haloperidol (Haldol; brand not available as an oral tablet in the United States)

0.5 to 1 mg orally, twice daily; additional doses every four hours, as needed

Extrapyramidal symptoms, particularly with dosages greater than 3 mg per day; prolonged corrected QT interval on electrocardiography

Agent of choice; avoid intravenous use due to short duration of action; avoid in patients with withdrawal syndrome, hepatic insufficiency, or neuroleptic malignant syndrome

Atypical antipsychotics

Risperidone (Risperdal)

0.5 mg twice daily

Extrapyramidal effects equal or slightly less than with haloperidol; prolonged corrected QT interval on electrocardiography

Tested only in small, uncontrolled studies; associated with increased mortality in older patients with dementia

Olanzapine (Zyprexa)

2.5 to 5 mg daily

Quetiapine (Seroquel)

25 mg twice daily

Benzodiazepines

Lorazepam (Ativan)

Initial 0.5- to 1-mg dose orally; repeat every four hours, as needed

Paradoxical excitation, respiratory depression, oversedation

Should not be used unless patient has alcohol or benzodiazepine withdrawal, Parkinson disease, or neuroleptic malignant syndrome


note: Pharmacologic treatment of delirium should be short-term and considered in selected patients only when the cause is nonspecific and other interventions do not sufficiently control symptoms.

Adapted with permission from Inouye SK. Delirium in older persons [published correction appears in N Engl J Med. 2006;354(15):1655]. N Engl J Med. 2006;354(11):1164.

Table 4.   Pharmacologic Treatment of Delirium

View Table

Table 4.

Pharmacologic Treatment of Delirium

Medication Dosage Adverse effects Comments

Conventional antipsychotics

Haloperidol (Haldol; brand not available as an oral tablet in the United States)

0.5 to 1 mg orally, twice daily; additional doses every four hours, as needed

Extrapyramidal symptoms, particularly with dosages greater than 3 mg per day; prolonged corrected QT interval on electrocardiography

Agent of choice; avoid intravenous use due to short duration of action; avoid in patients with withdrawal syndrome, hepatic insufficiency, or neuroleptic malignant syndrome

Atypical antipsychotics

Risperidone (Risperdal)

0.5 mg twice daily

Extrapyramidal effects equal or slightly less than with haloperidol; prolonged corrected QT interval on electrocardiography

Tested only in small, uncontrolled studies; associated with increased mortality in older patients with dementia

Olanzapine (Zyprexa)

2.5 to 5 mg daily

Quetiapine (Seroquel)

25 mg twice daily

Benzodiazepines

Lorazepam (Ativan)

Initial 0.5- to 1-mg dose orally; repeat every four hours, as needed

Paradoxical excitation, respiratory depression, oversedation

Should not be used unless patient has alcohol or benzodiazepine withdrawal, Parkinson disease, or neuroleptic malignant syndrome


note: Pharmacologic treatment of delirium should be short-term and considered in selected patients only when the cause is nonspecific and other interventions do not sufficiently control symptoms.

Adapted with permission from Inouye SK. Delirium in older persons [published correction appears in N Engl J Med. 2006;354(15):1655]. N Engl J Med. 2006;354(11):1164.

The optimal treatment of delirium involves primary prevention, which includes the reduction of modifiable risk factors. A useful, validated predictive model for delirium (Table 5) incorporates four risk factors and places patients in low-, intermediate-, or high-risk groups.26 Those in the high-risk category have an approximately 80 percent chance of developing delirium while hospitalized.26 Hospital staff educational programs and patient interventional programs have been shown to successfully reduce delirium by up to 33 percent in at-risk patients.27 Nonpharmacologic interventions for reducing the risk of delirium include regular daily activities that are cognitively stimulating; correction of dehydration; early mobilization (bedside range-of-motion exercises if patient is bedridden); minimization of unnecessary noise and stimuli; promotion of good sleep hygiene; removal of urinary catheters and physical restraints, when indicated; repeated reorientation; and the use of eyeglasses or a magnifying lens.27

Table 5.

Predictive Model for the Risk of Delirium in Hospitalized Older Patients

Risk factor Points

Vision impairment

1

Cognitive impairment

1

Severe illness (APACHE score > 16, or nurse rating of severe)

1

Elevated blood urea nitrogen/serum creatinine ratio (> 18)

1

Total: ____________


note: Risk stratification using the point total: low risk = 0 points, 10 percent risk of developing delirium; intermediate risk = 1 or 2 points, 25 percent risk; high risk = 3 or 4 points, 80 percent risk.

APACHE = Acute Physiology and Chronic Health Evaluation.

Information from reference 26.

Table 5.   Predictive Model for the Risk of Delirium in Hospitalized Older Patients

View Table

Table 5.

Predictive Model for the Risk of Delirium in Hospitalized Older Patients

Risk factor Points

Vision impairment

1

Cognitive impairment

1

Severe illness (APACHE score > 16, or nurse rating of severe)

1

Elevated blood urea nitrogen/serum creatinine ratio (> 18)

1

Total: ____________


note: Risk stratification using the point total: low risk = 0 points, 10 percent risk of developing delirium; intermediate risk = 1 or 2 points, 25 percent risk; high risk = 3 or 4 points, 80 percent risk.

APACHE = Acute Physiology and Chronic Health Evaluation.

Information from reference 26.

A study of medically hospitalized patients found that, by addressing six risk factors, one third fewer cases of delirium occurred compared with the control group.27 The six factors included cognitive impairment, sleep deprivation, immobility, dehydration, vision impairment, and hearing impairment.27 However, for a multi-component intervention to be effective in reducing delirium frequency, it is essential that there is adherence to the strategies used in the intervention.28,29

Studies on prevention using antipsychotics are limited in number and only involve postoperative patients. A recent Cochrane review noted that prophylactic haloperidol after hip surgery did not reduce the incidence of delirium, but reduced its severity and duration.30

Prognosis

Prospective trials of patients older than 70 years who developed delirium while hospitalized found that approximately 12 percent had persistent delirium at discharge.31 The independent risk factors for persistent delirium were dementia, vision impairment, functional impairment, high comorbidity, and the use of physical restraints.30 Persistent delirium may take weeks to resolve, and can take months or longer in some cases.32

According to another prospective study, MMSE scores of patients with delirium at two months and at 12 months showed a decline of approximately three points (out of 30). Patients with baseline dementia and delirium had a five-point reduction in MMSE scores at 12 months. Almost 40 percent of these patients required placement in a skilled nursing facility.31,32 Functional status also had a greater decline at 12 months compared with similarly matched patients without delirium. At 12 months, the mortality rate was 38 percent for patients with delirium, compared with 12 percent for those in the control group.4 Another study found a similar one-year mortality rate of 41 percent.33 Patients with the hypoactive subtype of delirium had the highest one-year mortality; this group was 1.62 times more likely to die compared with patients who had the hyperactive or mixed subtype.33

Hospital staff education programs and focusing on caregiver-patient interaction has been shown to significantly reduce the duration of delirium, length of hospital stay, and mortality in patients with delirium.29,34 Patients who receive these interventions may still require placement in a skilled nursing facility, but have shorter lengths of stay in the facility, saving approximately 15 percent in medical costs.35

The Author

MARCIA O. MILLER, MD, is an assistant clinical professor in the Department of Community Health and Family Medicine at the University of Florida college of Medicine, Gainesville. She is also the codirector of the hospitalist service at Shands AGH, which is part of the University of Florida Health System. Dr. Miller received her medical degree from the University of Iowa College of Medicine, Iowa City, and completed a residency in family medicine at the University of Florida.

Address correspondence to Marcia O. Miller, MD, Dept. of Community Health and Family Medicine, University of Florida College of Medicine, P.O. Box 100237, N107, Gainesville, FL 32610-0237 (e-mail: marcia.miller@shands.ufl.edu). Reprints are not available from the author.

Author disclosure: Nothing to disclose.

REFERENCES

1. Siddiqi N, House AO, Holmes JD. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing. 2006;35(4):350–364.

2. Centers for Medicare and Medicaid Services. 2004 CMS statistics. Washington, DC: U.S. Department of Health and Human Services; 2004. http://www.cms.hhs.gov/CapMarketUpdates/Downloads/2004CMSstats.pdf. Accessed June 10, 2008.

3. Agostini JV, Inouye SK. Delirium. In: Hazzard WR. Principles of Geriatric Medicine and Gerontology. 5th ed. New York, NY: McGraw-Hill Professional; 2003:1503–1515.

4. McCusker J, Cole M, Abrahamowicz M, Primeau F, Belzile E. Delirium predicts 12-month mortality. Arch Intern Med. 2002;162(4):457–463.

5. Inouye SK. Delirium in hospitalized older patients. Clin Geriatr Med. 1998;14(4):745–764.

6. Gillis AJ, MacDonald B. Unmasking delirium. Can Nurse. 2006;102(9):18–24.

7. Cole MG. Delirium in elderly patients. Am J Geriatr Psychiatry. 2004;12(1):7–21.

8. Ranhoff AH, Rozzini R, Sabatini T, Cassinadri A, Boffelli S, Trabucchi M. Delirium in a sub-intensive care unit for the elderly: occurrence and risk factors. Aging Clin Exp Res. 2006;18(5):440–445.

9. Fong TG, Bogardus ST Jr, Daftary A, et al. Cerebral perfusion changes in older delirious patients using 99mTc HMPAO SPECT. J Gerontol A Biol Sci Med Sci. 2006;61(12):1294–1299.

10. Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA. 1996;275(11):852–857.

11. Inouye SK. Delirium in older persons [published correction appears in N Engl J Med. 2006;354(15):1655]. N Engl J Med. 2006;354(11):1157–1165.

12. Ely EW. Delirium in the intensive care unit. In: Hall JB, Schmidt GA, Wood LDH, eds. Principles of Critical Care. 3rd ed. New York, NY: McGraw-Hill; 2005:975–984.

13. Trzepacz PT. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry. 2000;5(2):132–148.

14. Broadhurst C, Wilson K. Immunology of delirium: new opportunities for treatment and research. Br J Psychiatry. 2001;179288–289.

15. Zafirau B. Troubleshooting delirium in elderly inpatients. Psychiatric Times. 2007;24(7):64–67. http://www.psychiatrictimes.com/display/article/10168/54886. Accessed July 3, 2008.

16. Borugeois JA, Seaman JS, Servis ME. Delirium, dementia and amnestic and other cognitive disorders. In: Hales RE, Yudofsky SC, eds. The American Psychiatric Publishing Textbook of Clinical Psychiatry. 4th ed. Washington, DC: American Psychiatric Publishing; 2003.

17. Wang MD, Liao S, Amin AN. Altered mental status: delirium. In: Williams M, ed. Comprehensive Hospital Medicine: An Evidence Based Approach. Philadelphia, Pa.: Saunders Elsevier; 2007:719–723.

18. American Psychiatric Association. Practice guideline for the treatment of patients with delirium. Am J Psychiatry. 1999;156(5 suppl):1–20.

19. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113(12):941–948.

20. de Rooij SE, Schuurmans MJ, van der Mast RC, Levi M. Clinical subtypes of delirium and their relevance for daily clinical practice: a systematic review. Int J Geriatr Psychiatry. 2005;20(7):609–615.

21. Brown MM, Hachinski VC. Acute confusional states and delirium. In: Wilson JD, Braunwald E, Isselbacher KJ, et al., eds. Harrison's Principles of Internal Medicine. 12th ed. New York, NY: McGraw-Hill; 1991:186–188.

22. Flach EW, Coakley TA, Mensching JJ. Delirium and acute confusional states. In: Humphries R, ed. Current Emergency Diagnosis and Treatment. 5th ed. New York, NY: Lange Medical Books/McGraw-Hill; 2004:391–395.

23. Cook IA. Guideline watch: practice guideline for the treatment of patients with delirium. Arlington, Va.: American Psychiatric Association; 2004. http://www.psychiatryonline.com/pracGuide/loadGuidelinePdf.aspx?file=Delirium.watch. Accessed August 8, 2008.

24. Seitz DP, Gill SS, van Zyl LT. Antipsychotics in the treatment of delirium: a systematic review. J Clin Psychiatry. 2007;68(1):11–21.

25. Rea RS, Battistone S, Fong JJ, Devlin JW. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients. Pharmacotherapy. 2007;27(4):588–594.

26. Inouye SK, Viscoli CM, Horwitz RI, Hurst LD, Tinetti ME. A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med. 1993;119(6):474–481.

27. Inouye SK, Bogardus ST Jr, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999;340(9):669–676.

28. Inouye SK, Zhang Y, Jones RN, Kiely DK, Yang F, Marcantonio ER. Risk factors for delirium at discharge: development and validation of a predictive model. Arch Intern Med. 2007;167(13):1406–1413.

29. Lundström M, Edlund A, Karlsson S, Brännström B, Bucht G, Gustafson Y. A multifactorial intervention program reduces the duration of delirium, length of hospitalization, and mortality in delirious patients. J Am Geriatr Soc. 2005;53(4):622–628.

30. Siddiqi N, Stockdale R, Britton AM, Holmes J. Interventions for preventing delirium in hospitalised patients. Cochrane Database Syst Rev. 2007;(2):CD005563.

31. McCusker J, Cole M, Dendukuri N, Han L, Belzile E. The course of delirium in older medical inpatients: a prospective study. J Gen Intern Med. 2003;18(9):696–704.

32. McCusker J, Cole M, Dendukuri N, Belzile E, Primeau F. Delirium in older medical inpatients and subsequent cognitive and functional status: a prospective study. CMAJ. 2001;165(5):575–583.

33. Kiely DK, Jones RN, Bergmann MA, Marcantonio ER. Association between psychomotor activity delirium subtypes and mortality among newly admitted post-acute facility patients. J Gerontol A Biol Sci Med Sci. 2007;62(2):174–179.

34. Inouye SK, Bogardus ST Jr, Williams CS, Leo-Summers L, Agostini JV. The role of adherence on the effectiveness of nonpharmacologic interventions. Arch Intern Med. 2003;163(8):958–964.

35. Leslie DL, Zhang Y, Bogardus ST, Holford TR, Leo-Summers LS, Inouye SK. Consequences of preventing delirium in hospitalized older adults on nursing home costs. J Am Geriatr Soc. 2005;53(3):405–409.



Copyright © 2008 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Download PDF
  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

More in Pubmed

Navigate this Article